Open Access

LDL Management in ACS: Lower is better but is Earlier better?

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Prevention
Session type: Industry Live
Sponsored by Amgen (Europe) GmbH
Date: 1 September 2020
Time: 17:30 - 18:15

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

LDL Management in ACS: Lower is better but is Earlier better? - Sponsored by Amgen (Europe) GmbH


Does earlier treatment impact CV outcomes?

Speaker: Professor M. Sabatine (Boston, US)

Striking while the plaque is hot: emerging evidence.

Speaker: Assistant Professor T. Leucker (Baltimore, US)
Speaker: Professor S. Nicholls (Melbourne, AU)

What is the relevance to everyday practice?

Speaker: Professor G. Montalescot (Paris, FR)

Live Panel discussion and close.


4 speakers from this session

Professor Marc Sabatine

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
16 presentations
0 follower

Assistant Professor Thorsten Leucker

Johns Hopkins University, Baltimore (United States of America)
1 presentation
0 follower

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
36 presentations
1 follower

Professor Gilles Montalescot

Sorbonne University, Paris (France)
24 presentations
1 follower

This platform is supported by

logo Novo Nordisk